Hsiao Jane PH D's Form 4 filing
Opko Health, Inc. (OPK) · filed Jan 8, 2024
- Accession no.
- 0000950170-24-002743
- Filed
- Jan 8, 2024, 9:10 AM ET
- Trade date
- Jan 4-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $130.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hsiao Jane PH DCIK 0001188834 | Director, Officer (Vice Chairman & CTO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Common Stock | PPurchaseAcquired | +150,010 | $0.8726 | +$130,898.73 | 27,849,880 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | 5% Convertible Notes due 2025 | DReturned to the companyDisposed | – | – | – | – | Direct | |
| Jan 4, 2024 | 3.75% Convertible Notes due 2029 | AGrant or awardAcquired | – | – | – | – | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.